Literature DB >> 7047400

Humoral immunity in leprosy: immunoglobulin G and M antibody responses to Mycobacterium leprae in relation to various disease patterns.

J Touw, E M Langendijk, G L Stoner, A Belehu.   

Abstract

A solid-phase radioimmunoassay, applying whole Mycobacterium leprae as antigen and radiolabeled protein A from Staphylococcus aureus as antibody-detecting reagent, was used for the determination of specific immunoglobulin G (IgG) and IgM antibody responses in leprosy patients. High IgG anti-M. leprae antibody levels were found in lepromatous leprosy patients, whereas the antibody response in tuberculoid leprosy patients varied from negative, i.e., comparable with responses measured in normal individuals, to strongly positive. In tuberculoid leprosy patients, a significant increase in IgG anti-M. leprae antibody levels was observed in the more widespread forms of the disease, but positive antibody responses were especially predominant among patients with active lesions. Lepromatous leprosy patients generally demonstrated high levels of both IgG and IgM anti-M. leprae antibodies, but no relation was found between the antibody responses and bacillary load or other clinical parameters. A marked decrease in specific IgG and IgM antibody levels was observed in lepromatous leprosy patients during their first year of treatment. Differences in mechanisms regulating the humoral immune response in tuberculoid and lepromatous leprosy patients were indicated, and the application of antibody assessments in leprosy control programs is discussed.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047400      PMCID: PMC551412          DOI: 10.1128/iai.36.3.885-892.1982

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Diagnosis of recent Herpes simplex infections. A modified immunofluorescent test for the detection of specific Herpes simplex IgM antibodies after staphylococcal adsorption of IgG.

Authors:  K Skaug; E Tjotta
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

2.  A rountine diagnostic test for IgA and IgM antibodies to rubella virus: absorption of IgG with Staphylococcus aureus.

Authors:  J Ankerst; P Christensen; L Kjellén; G Kronvall
Journal:  J Infect Dis       Date:  1974-09       Impact factor: 5.226

3.  Some immunologic aspects of leprosy.

Authors:  R J Rees; K R Chatterjee; J Pepys; R D Tee
Journal:  Am Rev Respir Dis       Date:  1965-12

4.  Significance of variations within the lepromatous group.

Authors:  D S Ridley; M F Waters
Journal:  Lepr Rev       Date:  1969-07       Impact factor: 0.537

5.  Recognition of two distinct groups of human IgM and IgA based on different binding to staphylococci.

Authors:  M Harboe; I Fölling
Journal:  Scand J Immunol       Date:  1974       Impact factor: 3.487

6.  A rapid slide-agglutination method for typing pneumococci by means of specific antibody adsorbed to protein A-containing staphylococci.

Authors:  G Kronvall
Journal:  J Med Microbiol       Date:  1973-05       Impact factor: 2.472

7.  IgA and IgM reacting with staphylococcal protein A.

Authors:  G McDowell; A Grov; P Oeding
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

8.  Differences in anti-protein A activity among IgG subgroups.

Authors:  G Kronvall; R C Williams
Journal:  J Immunol       Date:  1969-10       Impact factor: 5.422

9.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

10.  BCG antibody profiles in tuberculoid and lepromatous leprosy.

Authors:  N H Axelsen; M Harboe; O Closs; T Godal
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

View more
  9 in total

1.  Specificity of IgG subclass antibodies in different clinical manifestations of leprosy.

Authors:  S Dhandayuthapani; S Izumi; D Anandan; V N Bhatia
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

2.  Human monoclonal antibodies against Mycobacterium leprae.

Authors:  T Atlaw; D Kozbor; J C Roder
Journal:  Infect Immun       Date:  1985-07       Impact factor: 3.441

3.  Serology and leprosy: immunoassays comparing immunoglobulin G antibody responses to 28- and 30-kilodalton proteins purified from Mycobacterium bovis BCG.

Authors:  M C Pessolani; J M Peralta; F D Rumjanek; H M Gomes; M A Marques; E C Almeida; M H Saad; E N Sarno
Journal:  J Clin Microbiol       Date:  1991-10       Impact factor: 5.948

4.  Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.

Authors:  S N Cho; D L Yanagihara; S W Hunter; R H Gelber; P J Brennan
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

5.  A role for natural antibody in the pathogenesis of leprosy: antibody in nonimmune serum mediates C3 fixation to the Mycobacterium leprae surface and hence phagocytosis by human mononuclear phagocytes.

Authors:  L S Schlesinger; M A Horwitz
Journal:  Infect Immun       Date:  1994-01       Impact factor: 3.441

6.  Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.

Authors:  S J Brett; P Draper; S N Payne; R J Rees
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

7.  Analysis of the major antigenic determinants of the characteristic phenolic glycolipid from Mycobacterium leprae.

Authors:  S J Brett; S N Payne; P Draper; R Gigg
Journal:  Clin Exp Immunol       Date:  1984-04       Impact factor: 4.330

8.  Increased activated memory B-cells in the peripheral blood of patients with erythema nodosum leprosum reactions.

Authors:  Edessa Negera; Stephen L Walker; Yonas Bekele; Hazel M Dockrell; Diana N Lockwood
Journal:  PLoS Negl Trop Dis       Date:  2017-12-18

9.  Differential Expression of IFN-γ, IL-10, TLR1, and TLR2 and Their Potential Effects on Downgrading Leprosy Reaction and Erythema Nodosum Leprosum.

Authors:  Douglas Eulálio Antunes; Isabela Maria Bernardes Goulart; Mayara Ingrid Sousa Lima; Patrícia Terra Alves; Paula Cristina Brígido Tavares; Luiz Ricardo Goulart
Journal:  J Immunol Res       Date:  2019-11-07       Impact factor: 4.818

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.